GASP1 Receptor-Sorting Research Addressed Analgesic Tolerance, Not Global Cannabis Immunity
Changing the fate of a cannabinoid receptor after activation altered analgesic tolerance in a mechanistic study. That does not establish that preventing receptor loss would eliminate every unwanted effect of cannabis.
The work examined a sorting interaction
The supplied abstract describes physical interaction between CB1 and G-protein-associated sorting protein 1, or GASP1. This protein directs receptors toward lysosomal compartments associated with degradation.
The intervention linked mechanism and behavior
The interaction was required for agonist-induced CB1 downregulation in the reported spinal-neuron experiments. Uncoupling CB1 from GASP1 in mice also prevented tolerance to the tested cannabinoid-induced analgesic effect.
The endpoint remains important
Retained antinociception is not equivalent to preserved cognition, absence of dependence or a favorable overall safety profile. An intervention that maintains one drug response might also change other responses in ways the cited outcome does not measure.
The result supports receptor sorting as one mechanism worth investigating. It is not a human prescribing protocol, a reason to increase cannabis exposure or an individual biomarker of impairment. A tissue mechanism can help explain a behavioral observation without making every form of cannabinoid tolerance interchangeable. The specific interaction, nervous-system setting and antinociceptive test define the scope.
Related: interpreting cannabis tolerance claims.
Research cited
Tappe-Theodor A; Agarwal N; Katona I; Rubino T; Martini L; Swiercz J; Mackie K; Monyer H; Parolaro D; Whistler J; Kuner T; Kuner R. A molecular basis of analgesic tolerance to cannabinoids. The Journal of neuroscience : the official journal of the Society for Neuroscience (2007). doi:10.1523/JNEUROSCI.5648-06.2007. Findings discussed from the study abstract.
